Refarmed Chemicals, as a distinguished member of the pharmaceutical industry, introduces Finasteride—a vital medication primarily utilized for the treatment of male pattern hair loss, also known as androgenetic alopecia. This condition is common in adult men and involves a receding hairline coupled with thinning of the hair on the crown and temple, often resulting in baldness. Finasteride works effectively by inhibiting the action of dihydrotestosterone (DHT), a hormone with a significant role in promoting hair loss. Finasteride is presented as an oral tablet, with dosing options of either 1mg or 5mg. It is designed to be consumed once daily, and its effectiveness is optimal when taken consistently over time. Adherence to the prescribed dosage is crucial, as is awareness of its strictly adult male usage parameters, as outlined by its contraindications. Produced in full compliance with Good Manufacturing Practice (GMP) standards and verified through various analytical quality control measures, the medication is a white or almost white, crystalline powder. It displays excellent solubility across ethanol, methanol, and methylene chloride, ensuring efficient absorption when ingested. The substance maintains a high purity, with the assay indicating a 98.0% - 102.0% content of the active ingredient, Finasteride, and has tight controls on impurities to ensure patient safety. Further considering safety, it is pivotal to acknowledge the contraindications and side effects Finasteride might present, such as decreased libido and erectile dysfunction. It's also necessary to take precautionary measures regarding potential interactions with other medications and its inappropriate use in women or children, as well as during pregnancy and breastfeeding. For optimal results and patient safety, tablets should be stored in controlled room temperatures, shielded from light and moisture. Our commitment to quality transcends the meticulously crafted tablets to encompass our service and reliability. We extend a partnership towards delivering growth in healthcare, ensuring that our prospective customers receive a product that balances robust efficacy with comprehensive safety measures.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Benserazide Hydrochloride, offered under REFARMED CHEMICALS—a subsidiary of the DKSH Group—is an essential pharmaceutical ingredient tailored for the robust demands of the medical industry. Specifically formulated for the management of Parkinson’s disease, Benserazide Hydrochloride serves as a monoamine oxidase B (MAO-B) inhibitor. When synergistically combined with levodopa, it not only amplifies the efficacy of the treatment but also mitigates associated side effects such as nausea, enhancing the quality of life for patients suffering from this neurodegenerative condition. Our Benserazide Hydrochloride emerges as a white to off-white crystalline powder, a testament to its purity and quality. The compound exhibits admirable water solubility, ensuring ease of formulation and bioavailability. Its molecular identity, C10H14N2O3·HCl, with a molecular weight of 234.7 g/mol, aligns with rigorous pharmaceutical prerequisites. Our product delivers through a strict adherence to quality with an assay value ranging from 98.5% to 101.0%, guaranteeing a high-caliber substance with minimal impurity content. REFARMED CHEMICALS prioritizes safety and compliance, validating Benserazide Hydrochloride's authenticity with the IR and Chlorides test among others, and acknowledges the product’s conscientious solubility in water and minimal solubility in anhydrous ethanol. We maintain stringent control on residual solvents, ensuring ethanol levels remain below 5000 ppm and methanol below 3000 ppm. Administered orally, this pharmaceutical agent's dosage is contingent upon individual patient needs and medical recommendations, subject to professional healthcare guidance. Despite its profound benefits, it should be noted that Benserazide Hydrochloride is contraindicated for patients with severe hepatic or renal impairments and requires cautious use in patients with a history of cardiovascular diseases, orthostatic hypotension, or psychiatric conditions. Interaction with opioids and antidepressants necessitates careful management. Upholding the highest standards, our product is compliant with Good Manufacturing Practice (GMP) and holds the Certificate of Suitability (CEP)—a rigorous certification ensuring consistency in high-quality production for our corporate customers. With REFARMED CHEMICALS, you are guaranteed a product that not only addresses the therapeutic needs but also embodies the precision and reliability sought after in the pharmaceutical industry.

Products still subject to third-party patent protection might be available solely for R&D purposes.